MARKETSDr Reddy’s Rises After US FDA Nod for Cancer BiosimilarTabassum ChaudharyAugust 3, 2026August 3, 2026 August 3, 2026August 3, 2026 Dr Reddy’s Laboratories touched a day high of ₹1,182 after the company disclosed in an exchange filing that it received US FDA approval. The approval...